{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:29Z","timestamp":1791821129011,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00772","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T06:56:43Z","timestamp":1498805803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":84,"title":["Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Vera M.","family":"Kroesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias I.","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjip S.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Vilaplana","given":"Cristina","family":"Vilaplana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","volume-title":"Treatment of Tuberculosis: Guidelines","year":"2010"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/cid\/civ631","article-title":"Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the Pasteur-Bechamp debates","volume":"61","author":"Zumla","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/infdis\/jit153","article-title":"Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment","volume":"208","author":"Ivanyi","year":"2013","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrd4696","article-title":"Towards host-directed therapies for tuberculosis","volume":"14","author":"Zumla","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1128\/MMBR.00032-13","article-title":"Host-directed therapeutics for tuberculosis: can we harness the host?","volume":"77","author":"Hawn","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00281-015-0537-x","article-title":"Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review","volume":"38","author":"Kiran","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tube.2013.09.004","article-title":"Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis","volume":"94","author":"Marzo","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488709788186021","article-title":"A general framework for the evaluation of clinical trial quality","volume":"4","author":"Berger","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"B10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/0883073811398132","article-title":"The role of aspirin in childhood tuberculous meningitis","volume":"26","author":"Schoeman","year":"2011","journal-title":"J Child Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0041-3879(79)90051-5","article-title":"Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration","volume":"60","author":"Horsfall","year":"1979","journal-title":"Tubercle"},{"key":"B12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.7326\/0003-4819-60-5-898","article-title":"Inhibition of pyrazinamide hyperuricemia by small doses of acetylsalicylic acid","volume":"60","author":"Petty","year":"1964","journal-title":"Ann Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/AAC.01145-06","article-title":"Aspirin antagonism in isoniazid treatment of tuberculosis in mice","volume":"51","author":"Byrne","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2249.1990.tb05192.x","article-title":"Role of antigen-presenting cells in variation in immunogenicity of mycobacteria","volume":"79","author":"Shroff","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"B17","first-page":"506","article-title":"T-cell lung granulomas induced by sepharose-coupled Mycobacterium tuberculosis protein antigens: immunosuppressive phenomena reversed with cyclophosphamide and indomethacin","volume":"86","author":"Hernandez-Pando","year":"1995","journal-title":"Immunology"},{"key":"B18","first-page":"922","article-title":"In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium","volume":"42","author":"Dutta","year":"2004","journal-title":"Indian J Exp Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","article-title":"Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"B20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1474-4422(10)70038-7","article-title":"Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events","volume":"9","author":"Hankey","year":"2010","journal-title":"Lancet Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"Kramnik","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nature16451","article-title":"Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection","volume":"528","author":"Kimmey","year":"2015","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23089","DOI":"10.1038\/srep23089","article-title":"Mycobacterial escape from macrophage phagosomes to the cytoplasm represents an alternate adaptation mechanism","volume":"6","author":"Jamwal","year":"2016","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/infdis\/jit476","article-title":"Low-dose aspirin and ibuprofen\u2019s sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis","volume":"208","author":"Eisen","year":"2013","journal-title":"J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/eji.1830241108","article-title":"Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response","volume":"24","author":"Saha","year":"1994","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/01.inf.0000261126.60283.cf","article-title":"Coagulant and fibrinolytic status in tuberculous meningitis","volume":"26","author":"Schoeman","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jinf.2009.07.012","article-title":"Tuberculous cerebrovascular disease: a review","volume":"59","author":"Lammie","year":"2009","journal-title":"J Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1542\/peds.99.2.226","article-title":"Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis","volume":"99","author":"Schoeman","year":"1997","journal-title":"Pediatrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J Neurol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/bmb\/ldw019","article-title":"Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs","volume":"118","author":"Maitra","year":"2016","journal-title":"Br Med Bull"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/AAC.46.8.2636-2639.2002","article-title":"Salicylate reduces susceptibility of Mycobacterium tuberculosis to multiple antituberculosis drugs","volume":"46","author":"Schaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1472-765X.1995.tb01291.x","article-title":"Antibacterial activity of the anti-inflammatory compound ibuprofen","volume":"20","author":"Elvers","year":"1995","journal-title":"Lett Appl Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1073\/pnas.1309578110","article-title":"Involvement of protein IF2 N domain in ribosomal subunit joining revealed from architecture and function of the full-length initiation factor","volume":"110","author":"Simonetti","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e002672","DOI":"10.1136\/bmjopen-2013-002672","article-title":"Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay","volume":"3","author":"Guzman","year":"2013","journal-title":"BMJ Open"},{"key":"B37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.chembiol.2014.02.009","article-title":"DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs","volume":"21","author":"Yin","year":"2014","journal-title":"Chem Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00203-005-0037-9","article-title":"Gene expression profiling analysis of Mycobacterium tuberculosis genes in response to salicylate","volume":"184","author":"Denkin","year":"2005","journal-title":"Arch Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0924-8579(99)00159-4","article-title":"The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis","volume":"14","author":"Dastidar","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"B40","first-page":"86","article-title":"Antibacterial activity of the antiinflammatory agent diclofenac sodium","volume":"36","author":"Annadurai","year":"1998","journal-title":"Indian J Exp Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1016\/j.bmc.2005.12.042","article-title":"Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides","volume":"14","author":"Sriram","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"38915","DOI":"10.1074\/jbc.M206855200","article-title":"Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2","volume":"277","author":"Patel","year":"2002","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.bmc.2015.03.041","article-title":"Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore","volume":"23","author":"Salunke","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1073\/pnas.1214188109","article-title":"Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials","volume":"109","author":"Gold","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.saa.2014.02.135","article-title":"Anti-inflammatory drugs interacting with Zn (II) metal ion based on thiocyanate and azide ligands: synthesis, spectroscopic studies, DFT calculations and antibacterial assays","volume":"128","author":"Chiniforoshan","year":"2014","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"B47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jinorgbio.2009.01.014","article-title":"Organotin meclofenamic complexes: synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid \u2013 novel anti-tuberculosis agents","volume":"103","author":"Kovala-Demertzi","year":"2009","journal-title":"J Inorg Biochem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ijantimicag.2007.04.018","article-title":"Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874279300802010059","article-title":"Assessment of the efficacy of new anti-tuberculosis drugs","volume":"2","author":"Mitchison","year":"2008","journal-title":"Open Infect Dis J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00772\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T06:56:48Z","timestamp":1498805808000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00772\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2017.00772"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00772","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]},"article-number":"772"}}